Literature DB >> 18608811

Vesicular aceclofenac systems: a comparative study between liposomes and niosomes.

Maha Nasr1, Samar Mansour, Nahed D Mortada, A A Elshamy.   

Abstract

Vesicular delivery systems have been reported to serve as local depot for sustained drug release. Aceclofenac multilamellar liposomes and niosomes were prepared and a comparative study was done between them through evaluation of entrapment efficiency, particle size, shape, differential scanning calorimetry and in vitro drug release. A stability study was carried out by investigating the leakage of aceclofenac and the change in the vesicles particle size when stored at (2-8 degrees C) for 3 months. The anti-inflammatory effect of aceclofenac vesicles was assessed by the rat paw oedema technique. Results showed that the entrapment efficiency and the in vitro release of aceclofenac from the vesicles can be manipulated by varying the cholesterol content, the type of surfactant as well as the type of charge. Niosomes showed better stability than liposomes. Both vesicular systems showed significant sustained anti-inflammatory activity compared to the marketed product, with niosomes being superior to liposomes as manifested by both oedema rate and inhibition rate percentages suggesting their effectiveness as topical anti-inflammatory delivery systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608811     DOI: 10.1080/02652040802055411

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  25 in total

1.  Investigation of formulation variables and excipient interaction on the production of niosomes.

Authors:  Zerrin Sezgin-Bayindir; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

2.  Enhanced oral bioavailability of griseofulvin via niosomes.

Authors:  Pratap S Jadon; Virendra Gajbhiye; Rajesh S Jadon; Kavita R Gajbhiye; Narayanan Ganesh
Journal:  AAPS PharmSciTech       Date:  2009-10-24       Impact factor: 3.246

3.  Development and optimization of novel controlled-release pioglitazone provesicular powders using 3² factorial design.

Authors:  Marwa H Shukr; Nadia A Eltablawy
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

4.  Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment.

Authors:  Mai Shaaban; Maha Nasr; Abeer Attia Tawfik; Maha Fadel; Omaima Sammour
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

5.  Nonionic surfactant vesicles for delivery of RNAi therapeutics.

Authors:  Orapan Paecharoenchai; Lesheng Teng; Bryant C Yung; Lirong Teng; Praneet Opanasopit; Robert J Lee
Journal:  Nanomedicine (Lond)       Date:  2013-11       Impact factor: 5.307

6.  Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal.

Authors:  Heba F Salem; Adel A Ali; Yasmine K Rabea; Fatma I Abo El-Ela; Rasha A Khallaf
Journal:  Drug Deliv Transl Res       Date:  2022-05-27       Impact factor: 4.617

7.  Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.

Authors:  Fatma I Abo El-Ela; Khaled H Hussein; Hossny A El-Banna; Amr Gamal; Sherin Rouby; Ahmed M S Menshawy; El-Shimaa El-Nahass; Shehata Anwar; Mohamed M A Zeinhom; Heba F Salem; Marawa Ahmed Yahia Al-Sayed; Hala A El-Newery; Khaled A M Shokier; Khalid A El-Nesr; H I Hosein
Journal:  AAPS PharmSciTech       Date:  2020-11-18       Impact factor: 3.246

8.  Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.

Authors:  Heba F Salem; Rasha M Kharshoum; Fatma I Abo El-Ela; Amr Gamal F; Khaled R A Abdellatif
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

9.  Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.

Authors:  Zerrin Sezgin-Bayindir; Mustafa Naim Antep; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2014-09-10       Impact factor: 3.246

10.  Mitigation of Rheumatic Arthritis in a Rat Model via Transdermal Delivery of Dapoxetine HCl Amalgamated as a Nanoplatform: In vitro and in vivo Assessment.

Authors:  Heba Farouk Salem; Mohamed Mahmoud Nafady; Rasha Mostafa Kharshoum; Omnia Ahmed Abd El-Ghafar; Hanan Osman Farouk
Journal:  Int J Nanomedicine       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.